Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial

Matthew S. Davids, Danielle M. Brander, Haesook T. Kim, Svitlana Tyekucheva, Jad Bsat, Alexandra Savell, Jeffrey Hellman, Josie Bazemore, Karen Francoeur, Alvaro J. Alencar,

The Lancet Haematology · 2019 · 72 citations · 23 references

DOIFull text

Open access

Concepts

References

23